1 |
Adams G, Zekri J, Wong H, Walking J, Green JA (2010). Platinumbased adjuvant chemotherapy for early-stage epithelial ovarian cancer: single or combination chemotherapy? BJOG, 117, 1459-67.
DOI
|
2 |
Arikan SK, Kasap B, Yetimalar H et al (2014). Impact of prognostic factors on survival rates in patients with ovarian carcinoma. Asian Pac J Cancer Prev, 15, 6087-94.
DOI
|
3 |
Bell J, Brady MF, Young RC et al (2006). Randomized phase III trial of three versus six cycles. Gynecol Oncol, 102, 432-9.
DOI
|
4 |
Chan JK, Tian C, Teoh D et al, (2010). Survival after recurrence in early-stage high-risk epithelial ovarian cancer: a Gynecologic Oncology Group study. Gynecol Oncol, 116, 307-11.
DOI
|
5 |
Chan JK, Tian C, Fleming GF, et al (2010). The potential benefit of 6 vs. 3 cycles of chemotherapy in subsets of women with early-stage high-risk epithelial ovarian cancer: an exploratory analysis of a gynecologic oncology group study. Gynecol Oncol, 116, 301.
DOI
|
6 |
Colombo N, Guthrie D, Chiari S et al (2003). International Collaborative Ovarian Neoplasm trial 1: a randomized trial of adjuvant chemotherapy in women with early-stage ovarian cancer. J Natl Cancer Inst, 95, 125-32.
DOI
|
7 |
Collinson F, Qian W, Fossati R, et al; ICON1 collaborators, (2014). Optimal treatment of early-stage ovarian cancer. Ann Oncol, 25, 1165-71.
DOI
|
8 |
Dizon DS, Restivo A, Lomme M, et al (2008). For women receiving chemotherapy for clinically apparent early ovarian cancer, is there a benefit to surgical staging? Am J Clin Oncol, 31, 39.
DOI
|
9 |
Fotopoulou C, Braicu I, Sehouli J (2012). Fertility-sparing surgery in early epithelial ovarian cancer: a viable option? Obstet Gynecol Int, 2012, 238061.
|
10 |
Guvenal T, Dursun P, Hasdemir P, et al (2013). Effect of surgical staging on 539 patients with borderline ovarian tumors: a turkish gynecologic oncology group study. Gynecologic Oncology, 131, 546-50.
DOI
|
11 |
Jansaka N, Suprasert P (2014). Survival outcomes of recurrent epithelial ovarian cancer: experience from a Thailand northern tertiary care center. Asian Pac J Cancer Prev, 15, 10837-40.
|
12 |
Kajiyama H, Shibata K, Mizuno M, et al (2011). Fertility-sparing surgery in young women with mucinous adenocarcinoma of the ovary. Gynecol Oncol, 122, 334-8.
DOI
|
13 |
Kleppe M, Wang T, Van Gorp T, et al (2011). Lymph node metastasis in stages I and II ovarian cancer: a review. Gynecol Oncol, 123, 610-4.
DOI
|
14 |
Kajiyama H, Shibata K, Mizuno M, et al (2011). Fertility-sparing surgery in patients with clear-cell carcinoma of the ovary: is it possible? Hum Reprod, 26, 3297-02.
DOI
|
15 |
Kajiyama H (2014). Fertility sparing surgery in patients with early stage epithelial ovarian cancer: implication of survival analysis and lymphadenectomy. J Gynecol Oncol, 25, 270-1.
DOI
|
16 |
Karimi Zarchi M, Mousavi A, Gilani MM, et al (2011). Fertility sparing treatments in young patients with gynecological cancers: Iranian experience and literature review. Asian Pac J Cancer Prev, 12, 1887-92.
|
17 |
Kolomainen DF, A'Hern R, Coxon FY, et al (2003). Can patients with relapsed, previously untreated, stage I epithelial ovarian cancer be successfully treated with salvage therapy? J Clin Oncol, 21, 3113-8.
DOI
|
18 |
Lazarov N, Lazarov L, Lazarov S (2013). The role of adjuvant chemotherapy as a prognostic factor in patients with early stage of epithelian ovarian cancer (I - II stage). Akush Ginekol (Sofiia), 52, 58-61.
|
19 |
Malpica A, Deavers MT, Lu K, et al (2004). Grading ovarian serous carcinoma using a two-tier system. Am J Surg Pathol, 28, 496-504.
DOI
|
20 |
Maltaris T, Seufert R, Fischl F (2007). The effect of cancer treatment on female fertility and strategies for preserving fertility. Eur J Obstet Gynecol Reprod Biol, 130, 148-55.
DOI
|
21 |
Patrono MG, Minig L, Diaz-Padilla I, et al (2013). Borderline tumours of the ovary, current controversies regarding their. Ecancermedicalscience, 7, 379.
|
22 |
Mannel RS, Brady MF, Kohn EC, et al (2011). A randomized phase III trial of IV carboplatin and paclitaxel × 3 courses followed by observation versus weekly maintenance low-dose paclitaxel in patients with early-stage ovarian carcinoma: a Gynecologic Oncology Group Study. Gynecol Oncol, 122, 89-94.
DOI
|
23 |
National Comprehensive Cancer Network (NCCN), (2014). http://www.nccn.org/.
|
24 |
NCT01462890. http://www.ago-ovar.de/en/trials-closedtrials-15.html.
|
25 |
Perren TJ, Swart AM, Pfisterer J et al; ICON7 Investigators (2011). A phase 3 trial of bevacizumab in ovarian cancer, 365, 2484-96.
DOI
|
26 |
Raja FA, Chopra N, Ledermann JA (2012). Optimal first-line treatment in ovarian cancer. Ann Oncol, 23, 118-127.
DOI
|
27 |
Satoh T, Hatae M, Watanabe Y, et al (2010). Outcomes of fertility-sparing surgery for stage I epithelial ovarian cancer: a proposal for patient selection. J Clin Oncol, 28, 1727-32.
DOI
|
28 |
Siegel R, Naishadham D, Jemal A (2013). Cancer statistics. CA Cancer J Clin, 63, 11-30.
DOI
ScienceOn
|
29 |
Takada T, Iwase H, Iitsuka C, et al (2012). Adjuvant chemotherapy for stage I clear cell carcinoma of the ovary: an analysis of fully staged patients. Int J Gynecol Cancer, 22, 573-8.
DOI
|
30 |
Trimbos JB, Vergote I, Bolis G et al (2003). Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: european organisation for research and treatment of cancer-adjuvant chemotherapy in ovarian neoplasm trial. J Natl, 95, 113-25.
|
31 |
Young RC, Brady MF, Nieberg RK, et al (2003). Adjuvant treatment for early ovarian cancer: a randomized phase III trial of intraperitoneal 32P or intravenous cyclophosphamide and cisplatin--a gynecologic oncology group study. J Clin Oncol, 21, 4350.
DOI
|
32 |
Trimbos B, Timmers P, Pecorelli S et al (2010). Surgical staging and treatment of early ovarian cancer: long-term analysis from a randomized trial. J Natl Cancer Inst, 102, 982-7.
DOI
|
33 |
Tognon G, Carnazza M, Ragnoli M et al (2013). Prognostic factors in early-stage ovarian cancer. Ecancermedicalscience, 7, 325.
|
34 |
Winter-Roach BA, Kitchener HC, Lawrie TA (2012). Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer. Cochrane Database Syst Rev, 3, CD004706.
|